choline has been researched along with carboplatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baek, HM; Bahri, S; Chen, JH; Mehta, RS; Nalcioglu, O; Nie, K; Su, MY; Yu, HJ | 1 |
Brenton, JD; Crawford, RA; Earl, HM; Gill, AB; Graves, MJ; Griffiths, JR; Hodgkin, C; Jimenez-Linan, M; Joubert, I; Kataoka, MY; Lomas, DJ; McLean, MA; Priest, AN; Sala, E | 1 |
2 other study(ies) available for choline and carboplatin
Article | Year |
---|---|
Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Choline; Contrast Media; Cyclophosphamide; Doxorubicin; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Neoadjuvant Therapy; Paclitaxel; ROC Curve; Statistics, Nonparametric; Trastuzumab; Treatment Outcome | 2009 |
Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Biomarkers, Tumor; CA-125 Antigen; Carboplatin; Choline; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Spectroscopy; Middle Aged; Organometallic Compounds; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Prospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed | 2012 |